Cargando…
Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG
Vaccination is the most efficient way to fight the Covid epidemic. However, suspicion of severe hypersensitivity to PEG (PolyEthylen Glycol) usually constitutes a vaccine contraindication. We report the case of a patient with a proven allergy to PEG and skin sensitization to the COMIRNATY vaccine (P...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400452/ https://www.ncbi.nlm.nih.gov/pubmed/34484471 http://dx.doi.org/10.1016/j.reval.2021.07.007 |
_version_ | 1783745318233309184 |
---|---|
author | Huynh, V.A. Janssen, C. Beaumier, L. |
author_facet | Huynh, V.A. Janssen, C. Beaumier, L. |
author_sort | Huynh, V.A. |
collection | PubMed |
description | Vaccination is the most efficient way to fight the Covid epidemic. However, suspicion of severe hypersensitivity to PEG (PolyEthylen Glycol) usually constitutes a vaccine contraindication. We report the case of a patient with a proven allergy to PEG and skin sensitization to the COMIRNATY vaccine (PEG in its composition). He was able to benefit from the vaccine under the 5-step desensitization protocol. Conclusions: Specific allergological management should be offered to patients suspected of severe hypersensitivity to PEG and other vaccine excipients. We propose a solution for Comirnaty administration for patients with a proven severe allergy to PEG. |
format | Online Article Text |
id | pubmed-8400452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84004522021-08-30 Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG Huynh, V.A. Janssen, C. Beaumier, L. Rev Fr Allergol (2009) Fait Clinique Vaccination is the most efficient way to fight the Covid epidemic. However, suspicion of severe hypersensitivity to PEG (PolyEthylen Glycol) usually constitutes a vaccine contraindication. We report the case of a patient with a proven allergy to PEG and skin sensitization to the COMIRNATY vaccine (PEG in its composition). He was able to benefit from the vaccine under the 5-step desensitization protocol. Conclusions: Specific allergological management should be offered to patients suspected of severe hypersensitivity to PEG and other vaccine excipients. We propose a solution for Comirnaty administration for patients with a proven severe allergy to PEG. Elsevier Masson SAS. 2022-05 2021-08-28 /pmc/articles/PMC8400452/ /pubmed/34484471 http://dx.doi.org/10.1016/j.reval.2021.07.007 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Fait Clinique Huynh, V.A. Janssen, C. Beaumier, L. Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title | Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title_full | Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title_fullStr | Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title_full_unstemmed | Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title_short | Induction de tolérance au vaccin à ARN COMIRNATY chez un patient avec une hypersensibilité allergique sévère au PEG |
title_sort | induction de tolérance au vaccin à arn comirnaty chez un patient avec une hypersensibilité allergique sévère au peg |
topic | Fait Clinique |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400452/ https://www.ncbi.nlm.nih.gov/pubmed/34484471 http://dx.doi.org/10.1016/j.reval.2021.07.007 |
work_keys_str_mv | AT huynhva inductiondetoleranceauvaccinaarncomirnatychezunpatientavecunehypersensibiliteallergiquesevereaupeg AT janssenc inductiondetoleranceauvaccinaarncomirnatychezunpatientavecunehypersensibiliteallergiquesevereaupeg AT beaumierl inductiondetoleranceauvaccinaarncomirnatychezunpatientavecunehypersensibiliteallergiquesevereaupeg |